[1]薛媛媛,陈晓隆.OCT和OCTA生物学标志物在糖尿病性黄斑水肿中应用的研究进展[J].眼科新进展,2023,43(1):076-81.[doi:10.13389/j.cnki.rao.2023.0016]
　XUE Yuanyuan,CHEN Xiaolong.Research progress on the application of optical coherence tomography and angiography biomarkers in diabetic macular edema[J].Recent Advances in Ophthalmology,2023,43(1):076-81.[doi:10.13389/j.cnki.rao.2023.0016]
点击复制

OCT和OCTA生物学标志物在糖尿病性黄斑水肿中应用的研究进展/HTML
分享到：

《眼科新进展》[ISSN:1003-5141/CN:41-1105/R]

卷:
43卷
期数:
2023年1期
页码:
076-81
栏目:
文献综述
出版日期:
2023-01-05

文章信息/Info

Title:
Research progress on the application of optical coherence tomography and angiography biomarkers in diabetic macular edema
作者:
薛媛媛; 陈晓隆
110001　辽宁省沈阳市，中国医科大学附属盛京医院眼科
Author(s):
XUE Yuanyuan; CHEN Xiaolong
Department of Ophthalmology,Shengjing Hospital of China Medical University,Shenyang 110001,Liaoning Province,China
关键词:
光学相干断层扫描; 光学相干断层扫描血管成像; 糖尿病性黄斑水肿; 血管内皮生长因子
Keywords:
optical coherence tomography;  optical coherence tomography angiography;  diabetic macular edema;  vascular endothelial growth factor
分类号:
R774
DOI:
10.13389/j.cnki.rao.2023.0016
文献标志码:
A
摘要:
糖尿病性黄斑水肿（DME）是导致糖尿病患者视力丧失的重要原因。光学相干断层扫描（OCT）检查能够清晰地显示黄斑区视网膜和脉络膜的细微结构，并对黄斑区各组织层次结构进行定性和定量分析。OCT血管成像（OCTA）是在OCT基础上发展而来的一种非侵入性血管成像技术，具有无创、高速、高分辨率的特点，可提供视网膜和脉络膜血管结构的三维图像，实现病变的定量检测和分层检测。通过OCT观察黄斑区视网膜的形态和细微结构及OCTA评估血流变化已成为DME的研究热点。本文就OCT和OCTA各生物学标志物在DME病程发展及其抗血管内皮生长因子药物治疗中的应用进行阐述，以期为评估 DME的严重程度、调整治疗方案并判断疾病预后提供参考。
Abstract:
Diabetic macular edema (DME) is the leading cause of visual loss in patients with diabetes mellitus. Optical coherence tomography (OCT) can reflect fine structures of the retina and choroid in the macular region and realize the qualitative and quantitative analysis of the tissues. Optical coherence tomography angiography (OCTA), a non-invasive technology developed based on OCT, can provide three-dimensional images of the vascular structure of the retina and choroid, achieving quantitative and stratified detection of lesions. It shows high efficiency and high resolution. The observation of macular retina morphology and microstructure by OCT and the evaluation of blood velocity change by OCTA have become research hotspots of DME. In this paper, the roles of OCT and OCTA biomarkers in DME progression and their application in anti-vascular endothelial growth factor drug therapy were described to provide a reference for evaluating the severity of DME, adjusting the therapeutic schedule and judging the prognosis.

参考文献/References:

［1］　BONFIGLIO V,REIBALDI M,PIZZO A,RUSSO A,MACCHI I,FARO G,et al.Dexamethasone for unresponsive diabetic macular oedema:optical coherence tomography biomarkers［J］.Acta Ophthalmol,2019,97(4):e540-e544.
［2］　CHATZIRALLI I,THEODOSSIADIS P,PARIKAKIS E,DIMITRIOU E,XIROU T,THEODOSSIADIS G,et al.Dexamethasone intravitreal implant in diabetic macular edema:real-life data from a prospective study and predictive factors for visual outcome［J］.Diabetes Ther,2017,8(6):1393-1404.
［3］　DEAK G G,BOLZ M,RITTER M,PRAGER S,BENESCH T,SCHMIDT-ERFURTH U.A systematic correlation between morphology and functional alterations in diabetic macular edema［J］.Invest Ophthalmol Vis Sci,2010,51(12):6710-6714.
［4］　GERENDAS B S,PRAGER S,DEAK G,SIMADER C,LAMMER J,WALDSTEIN S M,et al.Predictive imaging biomarkers relevant for functional and anatomical outcomes during ranibizumab therapy of diabetic macular oedema［J］.Br J Ophthalmol,2018,102(2):195-203.
［5］　REZNICEK L,CSERHATI S,SEIDENSTICKER F,LIEGL R,KAMPIK A,ULBIG M,et al.Functional and morphological changes in diabetic macular edema over the course of anti-vascular endothelial growth factor treatment［J］.Acta Ophthalmol,2013,91(7):e529- e536.
［6］　KARST S G,LAMMER J,MITSCH C,SCHOBER M,MEHTA J,SCHOLDA C,et al.Detailed analysis of retinal morphology in patients with diabetic macular edema randomized to ranibizumab or triamcinolone treatment［J］.Graefes Arch Clin Exp Ophthalmol,2018,256(1):49-58.
［7］　ARF S,SAYMAN M I,HOCAOGLU M,ERSOZ M G,OZDEMIR H,KARACORLU M.Spectral domain optical coherence tomography classification of diabetic macular edema:a new proposal to clinical practice［J］.Graefes Arch Clin Exp Ophthalmol,2020,258(6):1165-1172.
［8］　GAUCHER D,SEBAH C,ERGINAY A,HAOUCHINE B,TADAYONI R,GAUDRIC A,et al.Optical coherence tomography features during the evolution of serous retinal detachment in patients with diabetic macular edema［J］.Am J Ophthalmol,2008,145(2):289-296.
［9］　CAMPOS A,CAMPOS E J,MARTINS J.Viewing the choroid:where we stand,challenges and contradictions in diabetic retinopathy and diabetic macular oedema［J］.Acta Ophthalmol,2017,95(5):446-459.
［10］　VUJOSEVIC S,TORRESIN T,BERTON M,BINI S,CONVENTO E,MIDENA E.Diabetic macular edema with and without subfoveal neuroretinal detachment:two different morphologic and functional entities［J］.Am J Ophthalmol,2017,181:149-155.
［11］　SHIMURA M,YASUDA K,YASUDA M,NAKAZAWA T.Visual outcome after intravitreal bevacizumab depends on the optical coherence tomographic patterns of patients with diffuse diabetic macular edema［J］.Retina,2013,33(4):740-747.
［12］　ERCALIK N Y,IMAMOGLU S,TURKSEVEN K E,YENEREL N M,BARDAK H,BARDAK Y.Influence of serous retinal detachment on the outcome of ranibizumab treatment in diabetic macular oedema［J］.Cutan Ocul Toxicol,2018,37(4):324-327.
［13］　KALDIRIM H,YAZGAN S,KIRGIZ A,ATALAY K,SAVUR F.A comparison study of ranibizumab and aflibercept in patients with naive diabetic macular edema in presence of serous retinal detachment［J］.Curr Eye Res,2019,44(9):987-993.
［14］　BOLUKBASI S,CAKIR A,ERDEN B,KARACA G.Comparison of the short-term effect of aflibercept and dexamethasone implant on serous retinal detachment in the treatment of naive diabetic macular edema［J］.Cutan Ocul Toxicol,2019,38(4):401-405.
［15］　WONG Y,STEEL D H W,HABIB M S,STUBBING-MOORE A,BAJWA D,AVERY P J.Vitreoretinal interface abnormalities in patients treatedwith ranibizumab for diabetic macular oedema［J］.Graefes Arch Clin Exp Ophthalmol,2017,255(4):733-742.
［16］　SADIQ M A,SOLIMAN M K,SARWAR S,AGARWAL A,HANOUT M,DEMIREL S,et al.Effect of vitreomacular adhesion on treatment outcomes in the ranibizumab for edema of the macula in diabetes (READ-3) study［J］.Ophthalmology,2016,123(2):324-329.
［17］　KULIKOV A N,SOSNOVSKII S V,BEREZIN R D,MALTSEV D S,OSKANOV D H,GRIBANOV N A.Vitreoretinal interface abnormalities in diabetic macular edema and effectiveness of anti-VEGF therapy:an optical coherence tomography study［J］.Clin Ophthalmol,2017,11:1995-2002.
［18］　SUN J K,LIN M M,LAMMER J,PRAGER S,SARANGI R,SILVA P S,et al.Disorganization of the retinal inner layers as a predictor of visual acuity in eyes with center-involved diabetic macular edema［J］.JAMA Ophthalmol,2014,132 (11):1309-1316.
［19］　DAS R, SPENCE G, HOGG R E, STEVENSON M,CHAKRAVARTHY U.Disorganization of inner retina and outer retinal morphology in diabetic macular edema［J］.JAMA Ophthalmol,2018,136(2):202-208.
［20］　PELOSINI L,HULL C C,BOYCE J F,MCHUGH D,STANFORD M R,MARSHALL J.Optical coherence tomography may be used to predict visual acuity in patients with macular edema［J］.Invest Ophthalmol Vis Sci,2011,52(5):2741-2748.
［21］　BALARATNASINGAM C,INOUE M,AHN S,MCCANN J,DHRAMI-GAVAZI E,YANNUZZI L A,et al.Visual acuity is correlated with the area of the foveal avascular zone in diabetic retinopathy and retinal vein occlusion［J］.Ophthalmology,2016,123(11):2352-2367.
［22］　SPAIDE R F.Volume-rendered optical coherence tomography of diabetic retinopathy pilot study［J］.Am J Ophthalmol,2015,160(6):1200-1210.
［23］　SAXENA S,RUIA S,PRASAD S,JAIN A,MISHRA N,NATU S M,et al.Increased serum levels of urea and creatinine are surrogate markers for disruption of retinal photoreceptor external limiting membrane and inner segment ellipsoid zone in type 2 diabetes mellitus［J］.Retina,2017,37:344-349.
［24］　SHEN Y,LIU K,XU X.Correlation between visual function and photoreceptor integrity in diabetic macular edema:spectral-domain optical coherence tomography［J］.Curr Eye Res,2016,41(3):391-399.
［25］　MAHESHWARY A S,OSTER S F,YUSON R M,CHENG L,MOJANA F,FREEMAN W R.The association between percent disruption of the photoreceptor imaer segment-outer segment junction and visual acuity in diabetic macular edema［J］.Am J Ophthahnology,2010,150(1):63-67.
［26］　DE S,SAXENA S,KAUR A,MAHDI A A,MISRA A,SINGH M,et al.Sequential restoration of external limiting membrane and ellipsoid zone after intravitreal anti-VEGF therapy in diabetic macular oedema［J］.Eye,2021,35(5):1490-1495.
［27］　OZKAYA A,ALKIN Z,KARAKUCUK Y,KARATAS G,FAZIL K,ERDOGAN M G,et al.Thickness of the retinal photoreceptor outer segment layer in healthy volunteers and in patients with diabetes mellitus without retinopathy,diabetic retinopathy,or diabetic macular edema［J］.Saudi J Ophthalmol,2017,31:69-75.
［28］　CHUNG Y R,LEE S Y,KIM Y H,BYEON H E,KIM J H,LEE K.Hyperreflective foci in diabetic macular edema with serous retinal detachment:association with dyslipidemia［J］.Acta Diabetol,2020,57(7):861-866.
［29］　BOLZ M,SCHMIDT-ERFURTH U,DEAK G,MYLONAS G,KRIECHBAUM K,SCHOLDA C.Optical coherence tomographic hyperreflective foci:a morphologic sign of lipid extravasation in diabetic macular edema ［J］.Ophthalmology,2009,116(5):914-920.
［30］　UJI A,MURAKAMI T,NISHIJIMA K,AKAGI T,HORII T,ARAKAWA N,et al.Association between hyperreflective foci in the outer retina,status of photoreceptor layer,and visual acuity in diabetic macular edema［J］.Am J Ophthalmol,2012,153(4):710-717.
［31］　ZUR D,IGLICKI M,BUSCH C,INVERNIZZI A,MARIUSSI M,LOEWENSTEIN A.OCT biomarkers as functional outcome predictors in diabetic macular edema treated with dexamethasone implant.International Retina Group［J］.Ophthalmology,2018,125(2):267-275.
［32］　HWANG H S,CHAE J B,KIM J Y,KIM D Y.Association between hyperreflective dots on spectral-domain optical coherence tomography in macular edema and response to treatment［J］. Invest Ophthalmol Vis Sci,2017,58(13):5958-5967.
［33］　LIU S,WANG D,CHEN F.Hyperreflective foci in OCT image as a biomarker of poor prognosis in diabetic macular edema patients treating with conbercept in China［J］.BMC Ophthalmol,2019,19(1):157.
［34］　KANG J W,CHUNG H,CHAN K H.Correlation of optical coherence tomographic hyperreflective foci with visual outcomes in different patterns of diabetic macular edema［J］.Retina,2016,36(9):1630-1639.
［35］　YOSHITAKE T,MURAKAMI T,SUZUMA K,DODO Y,FUJIMOTO M,TSUJIKAWA A.Hyperreflective foci in the outer retinal layers as a predictor of the functional efficacy of ranibizumab for diabetic macular edema［J］.Sci Rep,2020,10(1):873.
［36］　MARKAN A,AGARWAL A,ARORA A,BAZGAIN K,RANA V,GUPTA V.Novel imaging biomarkers in diabetic retinopathy and diabetic macular edema［J］.Ther Adv Ophthalmol,2020,12:2515841420950513.
［37］　ROY R,SAURABH K,SHAH D,CHOWDHURY M,GOEL S.Choroidal hyperreflective foci:a novel spectral domain optical coherence tomography biomarker in eyes with diabetic macular edema［J］.Asia Pac J Ophthalmol (Phila),2019,8:314-318.
［38］　WANG W,LIU S,QIU Z,HE M,WANG L,LI Y,et al.Choroidal thickness in diabetes and diabetic retinopathy:a swept source OCT study［J］.Invest Ophthalmol Vis Sci,2020,61(4):29.
［39］　ELIWA T F,HEGAZY O S,MAHMOUD S S,ALMAAMON T.Choroidal thickness change in patients with diabetic macular edema［J］.Ophthalmic Surg Lasers Imaging Retina,2017,48:970-977.
［40］　ABADIA B,SUNEN I,CALVO P,BARTOL F,VERDES G,FERRERAS A.Choroidal thickness measured using swept-source optical coherence tomography is reduced in patients with type 2 diabetes［J］.PLoS One,2018,13(2):e0191977.
［41］　GUPTA C,TAN R,MISHRA C,KHANDELWAL N,RAMAN R,KIM R,et al.Choroidal structural analysis in eyes with diabetic retinopathy and diabetic macular edema-a novel OCT based imaging biomarker［J］.PLoS One,2018,13(12):e0207435.
［42］　KIM J T,LEE D H,JOE S G,KIM J G,YOON Y H.Changes in choroidal thickness in relation to the severity of retinopathy and macular edema in type 2 diabetic patients［J］.Invest Ophthalmology Visual Sci,2013,54:3378-3384.
［43］　AKSOY M,YILMAZ G,VARDARLI I,AKKOYUN I.Choroidal thickness after dexamethasone implant or aflibercept in patients with diabetic macular edema persistent to ranibizumab［J］.J Ocul Pharmacol Ther,2020,36(8):629-635.
［44］　KIM M,CHOI S Y,PARK Y H.Quantitative analysis of retinal and choroidal microvascular changes in patients with diabetes［J］.Sci Rep,2018,8(1):12146.
［45］　DI G,WEIHONG Y,XIAO Z,ZHIKUN Y,XUAN Z,YI Q,et al.A morphological study of the foveal avascular zone in patients with diabetes mellitus using optical coherence tomography angiography［J］.Graefe’s Arch Clin Exp Ophthalmol,2016,254(5):873-879.
［46］　ATTAALLAH H R,MOHAMED A A M,ALI M A.Macular vessels density in diabetic retinopathy:quantitative assessment using optical coherence tomography angiography［J］.Int Ophthalmol,2019,39(8):1845-1859.
［47］　LEE J,MOON B G,CHO A R,YOON Y H.Optical coherence tomography angiography of dme and its association with anti-VEGF treatment response［J］.Ophthalmology,2016,123(11):2368-2375.
［48］　MOON B G,UM T,LEE J,YOON Y H.Correlation between deep capillary plexus perfusion and long-term photoreceptor recovery after diabetic macular edema treatment［J］.Ophthalmol Retina,2018,2(3):235-243.
［49］　DASTIRIDOU A,KARATHANOU K,RIGA P,ANAGNOSTOPOULOU S,BALASUBRAMANIAN S,MATAFTSI A,et al.OCT angiography study of the macula in patients with diabetic macular edema treated with intravitreal aflibercept［J］.Ocul Immunol Inflamm,2021,29(5):926-931.
［50］　GILL A,COLE E D,NOVAIS E A,LOUZADA R N,DE C T,DUKER J S,et al.Visualization of changes in the foveal avascular zone in both observed and treated diabetic macular edema using optical coherence tomography angiography［J］.Int J Retina Vitreous,2017,3:19.
［51］　MASTROPASQUA R,TOTO L,MASTROPASQUA A,ALOIA R,DE N C,MATTEI P A,et al.Foveal avascular zone area and parafoveal vessel density measurements in differrent stages of diabetic retinopathy by optical coherence tomography angiography［J］.Int J Ophthalmol,2017,10(10):1545-1551.
［52］　SAMBHAV K,ABU-AMERO K K,CHALAM K V.Deep capillary macular perfusion indices obtained with OCT angiography correlate with degree of nonproliferative diabetic retinopathy［J］.Eur J Ophthalmol,2017,27(6):716-729.
［53］　TOTO L,DALOISIO R,DI N M,DI M G,DI S S,CIANCAGLINI M,et al.Qualitative and quantitative assessment of vascular changes in diabetic macular edema after dexamethasone implant using optical coherence tomography angiography［J］.Int J Mol Sci,2017,18(6):1181.
［54］　BUSCH C,WAKABAYASHI T,SATO T,FUKUSHIMA Y,HARA C,SHIRAKI N,et al.Retinal microvasculature and visual acuity after intravitreal aflibercept in diabetic macular edema:an optical coherence tomography angiography study［J］.Sci Rep,2019,9(1):1561.
［55］　SOROUR O A,SABROSA A S,YASIN A A,ARYA M,ISHIBAZAWA A,WITKIN A J,et al.Optical coherence tomography angiography analysis of macülar vessel density before and after anti-VEGF therapy in eyes with diabetic retinopathy［J］.Int Ophthalmol,2019,39(10):2361-2371.
［56］　COUTURIER A,MANE V,BONNIN S,ERGINAY A,MASSIN P,GAUDRIC A,et al.Capillary plexus anomalies in diabetic retinopathy on optical coherence tomography angiography［J］.Retina,2015,35(11):2384-2391.
［57］　ISHIBAZAWA A,NAGAOKA T,TAKAHASHI A,OMAE T,TANI T,SOGAWA K,et al.Optical coherence tomography angiography in diabetic retinopathy：a prospective pilot study［J］.Am J Ophthalmol,2015,160(1):35-44.
［58］　HARITOGLOU C,KERNT M,NEUBAUER A,GERSS J,OLIVEIRA C M,KAMPIK A,et al.Microaneurysm formation rate as a predictive marker for progression to clinically significant macular edema in nonproliferative diabetic retinopathy［J］.Retina,2014,34(1):157-164.
［59］　HASEGAWA N,NOZAKI M,TAKASE N,YOSHIDA M,OGURA Y.New insights into microaneurysms in the deep capillary plexus detected by optical coherence tomography angiography in diabetic macular edema［J］.Invest Ophthalmol Vis Sci,2016,57(9):348-355.
［60］　GHASEMI F K,IAFE N A,HUBSCHMAN J P,TSUI I,SADDA S R,SARRAF D.Optical coherence tomography angiography analysis of the foveal avascular zone and macular vessel density after anti-VEGF therapy in eyes with diabetic macular edema and retinal vein occlusion［J］.Invest Ophthalmol Vis Sci,2017,58(1):30-34.

相似文献/References:

[1]陈晓 李舒茵 牛超 李建新 陈慷.先天性视网膜劈裂症的影像学观察[J].眼科新进展,2012,32(11):000.
[2]闵红波 刘小红 花雷 韩文龙 储明慧 邵娟英.近视对OCT测量视网膜神经纤维层厚度的影响[J].眼科新进展,2012,32(12):000.
[3]张译心 巩琰 戴艳丽 黄厚斌 魏世辉.特发性脱髓鞘性视神经炎视网膜神经纤维层厚度和黄斑厚度的变化特点[J].眼科新进展,2013,33(2):000.
[4]马兰茗 金喜浓 金丽.光学相干断层扫描测量下方泪河高度诊断2型糖尿病患者眼干燥症的可行性[J].眼科新进展,2013,33(2):000.
[5]李朝晖 崔治华 胡晓英 孟丽珠 张敬维.糖尿病视网膜病变激光面积与疗效的分析[J].眼科新进展,2013,33(2):000.
[6]陈月芹 黄振平 薛春燕 葛轶睿.有晶状体眼虹膜固定型人工晶状体植入术后房角宽度的改变[J].眼科新进展,2013,33(6):000.
[7]杨世琳 杜改萍 郝玉华.频域OCT观察Vogt-小柳-原田病患者病程中黄斑中心凹的图像特点[J].眼科新进展,2013,33(6):000.
[8]辛晨 汪军 刘广峰 孟忻.增强成像技术光学相干断层扫描在在体脉络膜结构研究中的应用[J].眼科新进展,2013,33(6):000.
[9]马英慧 张铁民 齐建平.原发性开角型青光眼与慢性原发性闭角型青光眼视网膜神经纤维层厚度与视野缺损的关系[J].眼科新进展,2013,33(7):000.
[10]张海涛 杨玉新 毛永 丁晓丽 秦海霞 梁长华 郭英昌.青光眼与非炎症性缺血型视神经病变的傅立叶OCT扫描视神经形态学对比[J].眼科新进展,2013,33(8):000.
[11]王怀华,米东明,刘娜,等.COVID-19相关急性黄斑神经视网膜病变的眼底影像学特征[J].眼科新进展,2023,43(7):562.[doi:10.13389/j.cnki.rao.2023.0113]
　WANG Huaihua,MI Dongming,LIU Na,et al.Fundus imaging features of acute macular neuroretinopathy associated with COVID-19 infection[J].Recent Advances in Ophthalmology,2023,43(1):562.[doi:10.13389/j.cnki.rao.2023.0113]
[12]唐德荣,杨雨雯,石蕊,等.糖尿病视网膜神经损伤的病变规律及危险因素分析[J].眼科新进展,2023,43(12):964.[doi:10.13389/j.cnki.rao.2023.0191]
　TANG Derong,YANG Yuwen,SHI Rui,et al.Analysis of pathological regularity and related risk factors of retinal nerve injury in patients with diabetes mellitus[J].Recent Advances in Ophthalmology,2023,43(1):964.[doi:10.13389/j.cnki.rao.2023.0191]

备注/Memo

备注/Memo:
国家自然科学基金资助（编号：81570866）
更新日期/Last Update: 2023-01-05